)
Xintela (XINT) investor relations material
Xintela Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Clinical studies with XSTEM for knee osteoarthritis and difficult-to-heal leg ulcers have been completed, showing strong safety and efficacy results, including disease-modifying potential in osteoarthritis patients.
Targinta, the oncology subsidiary, entered a collaboration with Memorial Sloan Kettering Cancer Center for clinical development of integrin a10β1-targeted antibodies for aggressive sarcoma.
GMP operations continue to generate revenue through collaborations and are positioned for self-sufficiency.
Rights issue and loan financing raised approximately SEK 62 million to support ongoing operations and development.
Financial highlights
Q4 2025 income was TSEK 415, down from TSEK 1,090 in Q4 2024; full-year income was TSEK 2,282, down from TSEK 4,215.
Q4 2025 loss before tax was TSEK 17,343 (Q4 2024: loss of TSEK 11,712); full-year loss before tax was TSEK 50,158 (2024: loss of TSEK 41,534).
Loss per share for Q4 and full year remained at SEK 0.02 and SEK 0.07, respectively.
Cash and cash equivalents at year-end were TSEK 23,208, up from TSEK 16,680 the previous year.
Outlook and guidance
Next clinical study with XSTEM in osteoarthritis patients is being prepared, with ongoing discussions for investigator-initiated studies in Europe.
Results from the leg ulcer study are expected by the end of May, with plans for a phase II study in collaboration with the Burn Center in Linköping.
Business development efforts are focused on securing partnerships and licensing deals for XSTEM and Targinta's oncology assets.
Next Xintela earnings date
Next Xintela earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)